ANIP (ANI Pharmaceuticals) Short-Term Debt to Capital

Corporate company logo of ANI Pharmaceuticals (ANIP)

The debt-to-equity ratio for ANI Pharmaceuticals (ANIP) is 0.12. Stability in these metrics is supported by the absence of external sanctions and the localization of resources to combat raw material shortages. Business development relies on the creation of automated lines for complex liquid dosage forms. The company's success is based on patent protection and the efficient procurement of authorizations for the production of both branded and generic medicines.

Ratio of Short-Term Indebtedness to Capital: ANI Pharma (ANIP) for 07/04/2022 - 10/30/2026

Analytical breakdowns for ANI Pharmaceuticals

- stock quotes and analyst forecast:
Stock Price ANI Pharma|ANIP - Fair Value Consensus
- business market valuation indicators:
Market Capitalization ANI Pharmaceuticals Inc|ANIP - Enterprise Value
- book capitalization information:
Net Assets per Single Share ANI Pharmaceuticals|ANIP - Accounting Value of Company|Market Value to Book Value Ratio anipharmaceuticals.com|ANIP - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital ANI Pharmaceuticals|ANIP - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio ANI Pharmaceuticals, Inc.|ANIP - Aggregate Debt Obligations|Debt to Book Capitalization Ratio ANI Pharmaceuticals Inc|ANIP - Long-Term Debt|Company Current Liabilities ANI Pharmaceuticals|Quick Ratio anipharmaceuticals.com
- company profitability and valuation multiples indicators:
ANIP - Final Profit
Fundamental valuation:ANIP ANI Pharma
Brand item of ANI Pharmaceuticals Inc

Steady demand for niche drugs from ANI Pharmaceuticals (ANIP) minimizes dependence on market cycles, which is reflected in the moderate dynamics of short-term debt levels. This ratio compares liabilities with a maturity of up to one year against total capital, allowing investors to quickly assess current liquidity and the risk of excessive debt leverage that could limit the pace of business expansion.

Competitors of ANI Pharmaceuticals (ANIP)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio MNKD (MannKind)|AMPH (Amphastar Pharmaceuticals Inc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Pacira PCRX|ARS Corp (SPRY) - Current Liabilities to Capital|TBPH: Short-Term Debt to Equity Ratio|aquestive.com - Short-Term Loans to Capital Ratio|SCPH: Short-Term Debt to Capital|Tectonic Therapeutic - Ratio of Short-Term Indebtedness to Capital|TNXP (Tonix Pharmaceuticals Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital SXT China SXTC|Short-Term Debt to Equity Eupraxia Pharmaceuticals (EPRX)|BHST (bioharvest.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital EXOZ (eXoZymes)|Short-Term Debt to Capital Oramed ORMP|ENTX - Short-Term Debt to Equity|HYFT (MindWalk Therapeutics) - Short-Term Debt to Capital Ratio|ABVC: Short-Term Debt to Capital|CPIX - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio QNTM|FGEN: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Telomir Pharma (TELO)|RANI: Current Liabilities to Equity|Short-Term Debt to Capital SNYR (Synergy CHC)|Ratio of Short-Term Indebtedness to Capital RLYB|Lexaria - Short-Term Debt to Capital|PULM - Short-Term Debt to Capital|ftzy.com.cn (PTHL) - Short-Term Debt to Equity|Aptorum Group - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Lyra Therapeutics, Inc.|Short-Term Debt to Equity Ratio impactbiomedinc.com (IBO)|Short-Term Debt to Capital TNFA|Short-Term Debt to Capital cbdmd.com (YCBD)|Short-Term Debt to Capital PRFX (PainReform Limited)|CYTO - Short-Term Debt to Equity Ratio|Lipella Pharmaceuticals - Short-Term Debt to Capital|Current Liabilities to Capital optinose.com|PIRS (Pieris Pharmaceuticals, Inc.) - Short-Term Debt to Equity Ratio|Procaps Group (PROC) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio PTPI|QLI (Qilian International Corp) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital SLRN|Short-Term Debt to Capital Coefficient tffpharma.com